Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.01 (+20.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Emmaus Life Sciences (EMMA) recorded Depreciation & Amortization (CF) of $14,000 in Q2 2026, up 250.0% from $4,000 a year earlier but down 6.7% from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, Emmaus Life Sciences' Depreciation & Amortization (CF) came in at $59,000 as of Jun 30, 2026, up 210.5% year-over-year; for FY2025, it came in at $39,000, up 77.3% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $22,000 in FY2024 (-31.3%), $32,000 in FY2023 (-39.6%), $53,000 in FY2022 (-10.2%) and $59,000 in FY2021 (-1.7%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $4,000 in Q2 2025 to $15,000 in Q1 2026 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for four consecutive quarters, with growth averaging 93.2% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 250.0% in Q2 2026, against a decline of 53.8% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $15,000 (Q1 2026), $15,000 (Q4 2025) and $15,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn 14,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14,000.00
Mar 31, 2026 15,000.00
Dec 31, 2025 15,000.00
Sep 30, 2025 15,000.00
Jun 30, 2025 4,000.00
Mar 31, 2025 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 6,000.00
Sep 30, 2023 8,000.00
Jun 30, 2023 9,000.00
Mar 31, 2023 9,000.00
Dec 31, 2022 13,000.00
Sep 30, 2022 12,000.00
Jun 30, 2022 13,000.00
Mar 31, 2022 15,000.00
Dec 31, 2021 15,000.00
Sep 30, 2021 14,000.00
API Access

Emmaus Life Sciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EMMA&period=max&api_key=YOUR_API_KEY